- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02971059
Phenylalanine Requirement of Adults >65 Years.
September 14, 2018 updated by: Glenda Courtney-Martin, The Hospital for Sick Children
Phenylalanine Requirement of Healthy Older Adult Males and Females > 65 Years Determined by Direct Amino Acid Oxidation (DAAO) Method.
Currently there are insufficient published studies on amino acid requirements in the elderly.
Phenylalanine is one of the indispensable amino acids.
Low levels of phenylalanine has been observed in in the blood of older adults.
It is due the increased uptake by the liver and intestine.
This decreased levels of phenylalanine could lead to decreased skeletal muscle protein synthesis.
Requirement for elderly individuals have been set based on studies conducted in younger adults hence may be inaccurate.
The goal of this study is to directly measure the phenylalanine requirement of male and female elderly subjects over 65 years using the direct amino acid oxidation (DAAO) technique.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
- To determine and compare the phenylalanine requirement of healthy elderly male and female adults over the age of 65 years using the DAAO technique (by measuring the oxidation of L-[1-13 C] phenylalanine to 13 CO 2 [F 13 CO 2] ) in response to graded intakes of phenylalanine.
- To compare the requirement so derived to that of young healthy adult previously determined in our lab.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G1X8
- The Hospital for Sick Children
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
63 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy elderly males and females > 65 years
- Willingness to participate in the study and completed the screening procedures (height, weight, fasting blood sample and medical history questionnaire).
- No recent history of weight loss
- Absence of chronic disease or acute illness that could affect protein and AA metabolism (diabetes, cancer, liver or kidney disease, HIV, acute cold or flu, hypo or hyperthyroidism, rheumatoid arthritis treated with anti-inflammatory medications.
- Non-smoking
- Willingness to consume the diet provided
Exclusion Criteria:
- Presence of disease known to affect protein and AA metabolism (diabetes, cancer, liver or kidney disease, HIV, acute cold or flu, hypo or hyperthyroidism, rheumatoid arthritis treated with anti-inflammatory medications).
- On medications known to affect protein and amino acid metabolism (steroids).
- Recent significant weight loss.
- Individual on weight reducing diets.
- Inability to tolerate the diet
- Unwilling to have blood drawn from a venous access, or using a ventilated hood indirect calorimeter for the purposes of the study.
- Significant coffee consumption of more than 2 cups/day
- Significant alcohol consumption of more than one drink/day
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Adult Males >65 years
Participants will be seen initially for pre-study assessment (3 hour).
They will then be studied weekly for up to 7 levels of phenylalanine intake (7 Study periods).
Each study period will include a period of 3 days.
The first 2 days they will consume a liquid milkshake based diet at home.
On the 3rd day they will come to the hospital for a total of 8 hours.
|
Phenylalanine will be provided as graded intakes ranging from 7-40 mg/kg/day
|
Experimental: Adult Females >65 years
Participants will be seen initially for pre-study assessment (3 hour).
They will then be studied weekly for up to 7 levels of phenylalanine intake (7 Study periods).
Each study period will include a period of 3 days.
The first 2 days they will consume a liquid milkshake based diet at home.
On the 3rd day they will come to the hospital for a total of 8 hours.
|
Phenylalanine will be provided as graded intakes ranging from 7-40 mg/kg/day
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Phenylalanine Requirement
Time Frame: Baseline
|
To determine phenylalanine requirement by measuring the oxidation of 13CO2 in breath in response to graded phenylalanine intakes
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Glenda Courtney-Martin, Hospital for Sick Children, Toronto, Ontario
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2016
Primary Completion (Actual)
June 1, 2018
Study Completion (Actual)
June 1, 2018
Study Registration Dates
First Submitted
November 14, 2016
First Submitted That Met QC Criteria
November 18, 2016
First Posted (Estimate)
November 22, 2016
Study Record Updates
Last Update Posted (Actual)
September 18, 2018
Last Update Submitted That Met QC Criteria
September 14, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1000051682
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Older Adults
-
KU LeuvenCompletedHealthy Older Adults | Ill Older AdultsBelgium
-
Georgia Institute of TechnologyUniversity of FloridaNot yet recruiting
-
University of GuelphOntario Bean GrowersRecruiting
-
University of JordanRecruiting
-
University of Illinois at ChicagoNational Institute on Aging (NIA)Recruiting
-
University of BathCompletedOlder AdultsUnited Kingdom
-
University of JaenCompletedOlder AdultsColombia
-
Metabolic Technologies Inc.National Institute on Aging (NIA); Vanderbilt UniversityCompleted
-
Riphah International UniversityCompleted
-
East Carolina UniversityCompleted
Clinical Trials on Phenylalanine intake
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)Completed
-
University of ArkansasCompletedProtein MetabolismUnited States
-
University of ArkansasCompletedProtein MetabolismUnited States
-
Medical University of BialystokMinistry of Science and Higher Education, PolandCompletedDiabetes Mellitus, Type 2 | Metabolic Syndrome | Diet Modification | Overweight and Obesity | Genetic PredispositionPoland
-
University of LeedsCompletedHip Fracture (First Incidence of)United Kingdom
-
Texas State UniversityRecruitingEndothelial Dysfunction | Sodium IntakeUnited States
-
Maastricht University Medical CenterRecruitingGlucose Metabolism | Abdominal Obesity | Lipid Metabolism | Postprandial LipemiaNetherlands
-
University of ArkansasDairy Research InstituteCompletedMetabolic Syndrome